Recent progress in the pathophysiology of fibrinogen

Research output: Contribution to journalArticlepeer-review


A great deal of evidence suggests that fibrinogen is implicated in many vascular disorders resulting from atherothrombosis. However, it has not yet been possible either to establish with certainty whether elevated plasma fibrinogen levels cause, or arise as a consequence of, vascular pathology; or to include fibrinogen in the battery of laboratory tests widely used to predict the risk of thrombosis. This article provides an overview of the progress that has taken place in recent years in our understanding of the pathogenetic role of high plasma fibrinogen levels; the identification of genetic markers of atherothrombotic disease; and the clarification of the complex epidemiology of plasma fibrinogen levels as it relates to genotype and environment. The recent improvement in methodology used to measure plasma fibrinogen levels (which should lend to the wider use of fibrinogen assays in clinical practice) is also reviewed.

Original languageEnglish
Pages (from-to)25-30
Number of pages6
JournalEuropean Heart Journal
Issue numberSUPPL. A
Publication statusPublished - 1995


  • Atherosclerosis
  • Atherothrombosis
  • Chronic infection
  • Epidemiology
  • Fibrinogen assays
  • Fibrinogen standard
  • Genotype
  • Lifestyle modification

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Recent progress in the pathophysiology of fibrinogen'. Together they form a unique fingerprint.

Cite this